169 related articles for article (PubMed ID: 37191489)
1. MRI Features for Identifying
Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
[TBL] [Abstract][Full Text] [Related]
2.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
3. Secondary enucleated retinoblastoma with MYCN amplification.
Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
[No Abstract] [Full Text] [Related]
4. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
[TBL] [Abstract][Full Text] [Related]
7. High-Level
Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
9.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
10. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
Soliman SE; VandenHoven C; MacKeen LD; Héon E; Gallie BL
Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
[TBL] [Abstract][Full Text] [Related]
16. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
17. Mutational screening of germline
Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
19. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
[TBL] [Abstract][Full Text] [Related]
20. Association between MRI Findings and Causative Variations in Unilateral Retinoblastoma.
Rollins NK
Radiology; 2023 Jun; 307(5):e230852. PubMed ID: 37191487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
